X-linked acrogigantism syndrome: clinical profile and therapeutic responses

Investigation and management of tall stature

(2014) J. H. Davies et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Acromegaly and McCune-Albright Syndrome

(2014) Sylvie Salenave et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence of double pituitary adenomas in a surgical series: Clinical, histological and genetic features

(2014) F. Magri et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Somatostatin receptor ligands and resistance to treatment in pituitary adenomas

(2014) Daniel Cuevas-Ramos et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Constitutive Somatostatin Receptor Subtype-3 Signaling Suppresses Growth Hormone Synthesis

(2014) Tamar Eigler et al.   MOLECULAR ENDOCRINOLOGY

Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation

(2014) Giampaolo Trivellin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas

(2013) Misu Lee et al.   ACTA NEUROPATHOLOGICA

Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene

(2013) Albert Beckers et al.   ENDOCRINE REVIEWS

Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations

(2013) Marie-Lise Jaffrain-Rea et al.   ENDOCRINE-RELATED CANCER

Pituitary gigantism treated successfully with the growth hormone receptor antagonist, pegvisomant

(2013) A. Daniel et al.   INTERNAL MEDICINE JOURNAL

Carney complex and McCune Albright syndrome: An overview of clinical manifestations and human molecular genetics

(2013) Paraskevi Salpea et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Acromegaly induced by ectopic secretion of GHRH: A review 30 years after GHRH discovery

(2012) Françoise Borson-Chazot et al.   ANNALES D ENDOCRINOLOGIE

AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression

(2012) Leandro Kasuki et al.   ENDOCRINE-RELATED CANCER

Clinical Characteristics and Outcome of Acromegaly Induced by Ectopic Secretion of Growth Hormone-Releasing Hormone (GHRH): A French Nationwide Series of 21 Cases

(2012) Laetitia Garby et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Update in the CNS Response to Hypoglycemia

(2012) Rory J. McCrimmon   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Differential Ontogenetic Patterns of in vitro Desensitization to GHRH in Fetal and Neonatal Anterior Pituitary

(2012) R. Torronteras et al.   NEUROENDOCRINOLOGY

Hyperplasia–adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation

(2011) Chiara Villa et al.   ENDOCRINE-RELATED CANCER

Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study

(2010) Adrian F. Daly et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications

(2009) Marie-Lise Jaffrain-Rea et al.   ENDOCRINE-RELATED CANCER

Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly

(2009) Marily Theodoropoulou et al.   INTERNATIONAL JOURNAL OF CANCER

The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans

(2009) Feng Zhang et al.   NATURE GENETICS

A Microhomology-Mediated Break-Induced Replication Model for the Origin of Human Copy Number Variation

(2009) P. J. Hastings et al.   PLoS Genetics

Treatment of Pituitary Gigantism with the Growth Hormone Receptor Antagonist Pegvisomant

(2008) Naila Goldenberg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM